Page last updated: 2024-10-26

valproic acid and Hyperpotassemia

valproic acid has been researched along with Hyperpotassemia in 2 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Jutrić, D1
Đikić, D1
Boroš, A1
Odeh, D1
Gračan, R1
Beletić, A1
Jurčević, IL1
Kuo, YC1
Lin, YC1
Chen, PH1

Other Studies

2 other studies available for valproic acid and Hyperpotassemia

ArticleYear
Combined effects of valproate and naringin on kidney antioxidative markers and serum parameters of kidney function in C57BL6 mice.
    Arhiv za higijenu rada i toksikologiju, 2023, Sep-01, Volume: 74, Issue:3

    Topics: Animals; Antioxidants; Catalase; Female; Hyperkalemia; Kidney; Lipid Peroxidation; Male; Mice; Mice,

2023
Emerging Hyperkalemia Following Valproic Acid Use in an Elderly Patient With Late-Onset Mania.
    Journal of clinical psychopharmacology, 2016, Volume: 36, Issue:4

    Topics: Aged; Antimanic Agents; Bipolar Disorder; Female; Humans; Hyperkalemia; Valproic Acid

2016